UR
IBB icon

USCA RIA’s iShares Biotechnology ETF IBB Stock Holding History

USCA RIA’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$546K Hold
3,335
– – 0.03% 382
2021
Q1 		$502K Sell
3,335
-79,122
-96% -$12.6M 0.03% 380
2020
Q4 		$12.5M Buy
82,457
+13,068
+19% +$1.87M 0.88% 20
2020
Q3 		$9.4M Buy
69,389
+67,407
+3,401% +$9.14M 0.74% 24
2020
Q2 		$271K Hold
1,982
– – 0.02% 367
2020
Q1 		$214K Buy
1,982
+32
+2% +$3.68K 0.02% 361
2019
Q4 		$235K Buy
+1,950
New +$218K 0.02% 420
2019
Q3 		– Sell
-1,950
Closed -$213K – 463
2019
Q2 		$213K Hold
1,950
– – 0.02% 408
2019
Q1 		$218K Sell
1,950
-600
-24% -$65.8K 0.02% 390
2018
Q4 		$246K Sell
2,550
-5,984
-70% -$635K 0.03% 358
2018
Q3 		$1.04M Buy
8,534
+5,982
+234% +$704K 0.11% 221
2018
Q2 		$280K Hold
2,552
– – 0.03% 384
2018
Q1 		$272K Hold
2,552
– – 0.03% 380
2017
Q4 		$272K Sell
2,552
-1,798
-41% -$192K 0.03% 373
2017
Q3 		$450K Hold
4,350
– – 0.06% 294
2017
Q2 		$450K Buy
4,350
+1,368
+46% +$135K 0.06% 295
2017
Q1 		$292K Buy
2,982
+660
+28% +$63.2K 0.04% 345
2016
Q4 		$205K Sell
2,322
-48
-2% -$4.37K 0.03% 356
2016
Q3 		$229K Buy
+2,370
New +$225K 0.04% 339
2016
Q2 		– Sell
-2,412
Closed -$210K – 375
2016
Q1 		$210K Sell
2,412
-21,423
-90% -$1.92M 0.04% 321
2015
Q4 		$2.69M Buy
23,835
+3,036
+15% +$330K 0.58% 45
2015
Q3 		$2.1M Buy
20,799
+5,994
+40% +$719K 0.53% 53
2015
Q2 		$1.82M Buy
14,805
+12,753
+621% +$1.53M 0.48% 56
2015
Q1 		$235K Buy
+2,052
New +$226K 0.06% 294

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

USCA RIA's IBB Position: Q2 2021 in Review

USCA RIA held its iShares Biotechnology ETF (IBB) position steady in Q2 2021 at 3,335 shares worth $546K. The position accounts for 0.03% of the portfolio, ranked #382.

USCA RIA first reported a position in IBB in Q1 2015 and has held it in 24 quarters since. The position peaked at $12.5M in Q4 2020. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

  • USCA RIA held 3,335 shares of iShares Biotechnology ETF worth $546K as of Q2 2021.
  • USCA RIA left its iShares Biotechnology ETF share count unchanged in Q2 2021.
  • iShares Biotechnology ETF made up 0.03% of USCA RIA's portfolio in Q2 2021, its #382 holding.
  • USCA RIA first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 24 quarters since.
  • USCA RIA's iShares Biotechnology ETF position peaked at $12.5M in Q4 2020.
  • 863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.